These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26566104)

  • 21.
    Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
    Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
    Velarde-Miranda C; Gomez-Sanchez EP; Gomez-Sanchez CE
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):895-901. PubMed ID: 23829355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Inoue K; Yamazaki Y; Kitamoto T; Hirose R; Saito J; Omura M; Sasano H; Nishikawa T
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3477-3485. PubMed ID: 30020487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
    Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
    Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma.
    Scholl UI; Abriola L; Zhang C; Reimer EN; Plummer M; Kazmierczak BI; Zhang J; Hoyer D; Merkel JS; Wang W; Lifton RP
    J Clin Invest; 2017 Jun; 127(7):2739-2750. PubMed ID: 28604387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of KCNJ5 in familial and sporadic primary aldosteronism.
    Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA
    Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-Releasing Hormone Stimulate Aldosterone Production in a Subset of Aldosterone-Producing Adenoma.
    Kishimoto R; Oki K; Yoneda M; Gomez-Sanchez CE; Ohno H; Kobuke K; Itcho K; Kohno N
    Medicine (Baltimore); 2016 May; 95(20):e3659. PubMed ID: 27196470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NCI-H295R cell line as in vitro model of hyperaldosteronism lacks functional KCNJ5 (GIRK4; Kir3.4) channels.
    Kienitz MC; Mergia E; Pott L
    Mol Cell Endocrinol; 2015 Sep; 412():272-80. PubMed ID: 25998841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
    Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
    Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation.
    Murakami M; Yoshimoto T; Nakano Y; Tsuchiya K; Minami I; Bouchi R; Fujii Y; Nakabayashi K; Hashimoto K; Hata KI; Kihara K; Ogawa Y
    Biochem Biophys Res Commun; 2016 Aug; 476(4):614-619. PubMed ID: 27282482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
    Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
    J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.
    Lerario AM; Nanba K; Blinder AR; Suematsu S; Omura M; Nishikawa T; Giordano TJ; Rainey WE; Else T
    Endocr Relat Cancer; 2019 Apr; 26(4):463-470. PubMed ID: 30753137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in KCNJ5 gene cause hyperaldosteronism.
    Zennaro MC; Jeunemaitre X
    Circ Res; 2011 Jun; 108(12):1417-8. PubMed ID: 21659651
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel genes in primary aldosteronism.
    Fischer E; Beuschlein F
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):154-8. PubMed ID: 24739312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma.
    Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Mizobuchi A; Harada T; Yamaji T; Hashimoto Y; Yoshimura K; Nakano Y; Goto C; Yusoff FM; Nakashima A; Higashi Y
    Hypertens Res; 2023 Sep; 46(9):2213-2227. PubMed ID: 37463983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas.
    Gomez-Sanchez CE; Kuppusamy M; Gomez-Sanchez EP
    Mol Cell Endocrinol; 2015 Jun; 408():213-9. PubMed ID: 25496839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits?
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Hypertension; 2012 Feb; 59(2):196-7. PubMed ID: 22203746
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary aldosteronism and potassium channel mutations.
    Stowasser M
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy.
    Chang CH; Hu YH; Tsai YC; Wu CH; Wang SM; Lin LY; Lin YH; Satoh F; Wu KD; Wu VC
    Oncotarget; 2017 May; 8(18):29984-29995. PubMed ID: 28415786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on novel mechanisms of primary aldosteronism.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.